Viatris (VTRS) Equity Average (2019 - 2026)
Viatris (VTRS) recorded quarterly Equity Average of $14.7 billion in Q1 2026, down 1.87% quarter-over-quarter from $15.0 billion in Q4 2025, and down 14.34% on a YoY basis from $17.1 billion in Q1 2025.
Viatris (VTRS) Equity Average (2019 - 2026) Analysis & Trends
Viatris' Equity Average history runs 8 years deep, the most recent figure standing at $14.7 billion for Q1 2026.
- In Q1 2026, Equity Average fell 14.34% year-over-year to $14.7 billion; the TTM figure through Mar 2026 stood at $14.7 billion (down 14.34% YoY), while the FY2025 annual figure was $16.7 billion, down 14.72% from the prior year.
- Equity Average was $14.7 billion for Q1 2026 at Viatris, down from $15.0 billion in the prior quarter.
- In the past five years, Equity Average ranged from a high of $21.0 billion in Q1 2023 to a low of $14.7 billion in Q1 2026.
- Historically, Equity Average has averaged $18.8 billion across 5 years, with a median of $19.8 billion in 2024.
- The sharpest annual moves came in 2023 and 2025: Equity Average climbed 6.98% in 2023, then fell 22.12% in 2025.
- A 5-year view of Equity Average shows it stood at $20.1 billion in 2022, then rose by 2.68% to $20.7 billion in 2023, then retreated by 7.03% to $19.2 billion in 2024, then dropped by 22.12% to $15.0 billion in 2025, then dropped by 1.87% to $14.7 billion in 2026.
- The last three Equity Average figures came in at $14.7 billion (Q1 2026), $15.0 billion (Q4 2025), and $15.4 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 8.07 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 3.32 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 6.50 Bn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 409.63 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 3.33 Bn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 6.52 Bn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 1.79 Bn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 493.55 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 1.15 Bn |
| 10 | Viatris | - | - | 1.16 Bn | 14.68 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 14.68 Bn |
| Dec 31, 2025 | 14.96 Bn |
| Sep 30, 2025 | 15.39 Bn |
| Jun 30, 2025 | 15.61 Bn |
| Mar 31, 2025 | 17.14 Bn |
| Dec 31, 2024 | 19.21 Bn |
| Sep 30, 2024 | 19.66 Bn |
| Jun 30, 2024 | 19.77 Bn |
| Mar 31, 2024 | 20.24 Bn |
| Dec 31, 2023 | 20.67 Bn |
| Sep 30, 2023 | 20.85 Bn |
| Jun 30, 2023 | 20.89 Bn |
| Mar 31, 2023 | 21.00 Bn |
| Dec 31, 2022 | 20.13 Bn |
| Sep 30, 2022 | 19.49 Bn |
| Jun 30, 2022 | 20.13 Bn |
| Mar 31, 2022 | 20.47 Bn |
| Dec 31, 2021 | 20.82 Bn |
| Sep 30, 2021 | 21.17 Bn |
| Jun 30, 2021 | 21.31 Bn |